514 related articles for article (PubMed ID: 28869941)
1. Identifying Attenuating Mutations: Tools for a New Vaccine Design against Flaviviruses.
Khou C; Pardigon N
Intervirology; 2017; 60(1-2):8-18. PubMed ID: 28869941
[TBL] [Abstract][Full Text] [Related]
2. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
Lai CJ; Monath TP
Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441
[TBL] [Abstract][Full Text] [Related]
3. T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
Grifoni A; Voic H; Dhanda SK; Kidd CK; Brien JD; Buus S; Stryhn A; Durbin AP; Whitehead S; Diehl SA; De Silva AD; Balmaseda A; Harris E; Weiskopf D; Sette A
J Virol; 2020 May; 94(10):. PubMed ID: 32132233
[TBL] [Abstract][Full Text] [Related]
4. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccines for flaviviruses.
Putnak R; Porter K; Schmaljohn C
Adv Virus Res; 2003; 61():445-68. PubMed ID: 14714440
[No Abstract] [Full Text] [Related]
6. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
[TBL] [Abstract][Full Text] [Related]
7. Immunopathology of Zika virus infection.
Platt DJ; Miner JJ
Adv Virus Res; 2020; 107():223-246. PubMed ID: 32711730
[TBL] [Abstract][Full Text] [Related]
8. Flavivirus-induced antibody cross-reactivity.
Mansfield KL; Horton DL; Johnson N; Li L; Barrett ADT; Smith DJ; Galbraith SE; Solomon T; Fooks AR
J Gen Virol; 2011 Dec; 92(Pt 12):2821-2829. PubMed ID: 21900425
[TBL] [Abstract][Full Text] [Related]
9. Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype.
Heiss BL; Maximova OA; Pletnev AG
J Virol; 2011 Feb; 85(4):1464-72. PubMed ID: 21123372
[TBL] [Abstract][Full Text] [Related]
10. Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.
Huang CY; Silengo SJ; Whiteman MC; Kinney RM
J Virol; 2005 Jun; 79(12):7300-10. PubMed ID: 15919884
[TBL] [Abstract][Full Text] [Related]
11. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
[TBL] [Abstract][Full Text] [Related]
12. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
[TBL] [Abstract][Full Text] [Related]
13. Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis.
Xie X; Yang Y; Muruato AE; Zou J; Shan C; Nunes BT; Medeiros DB; Vasconcelos PF; Weaver SC; Rossi SL; Shi PY
mBio; 2017 Feb; 8(1):. PubMed ID: 28174309
[TBL] [Abstract][Full Text] [Related]
14. STAT5: a Target of Antagonism by Neurotropic Flaviviruses.
Zimmerman MG; Bowen JR; McDonald CE; Young E; Baric RS; Pulendran B; Suthar MS
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534033
[TBL] [Abstract][Full Text] [Related]
15. Flaviviruses and flavivirus vaccines.
Heinz FX; Stiasny K
Vaccine; 2012 Jun; 30(29):4301-6. PubMed ID: 22682286
[TBL] [Abstract][Full Text] [Related]
16. Live flavivirus vaccines: reasons for caution.
Seligman SJ; Gould EA
Lancet; 2004 Jun; 363(9426):2073-5. PubMed ID: 15207960
[TBL] [Abstract][Full Text] [Related]
17. A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection.
Smith JL; Jeng S; McWeeney SK; Hirsch AJ
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148804
[TBL] [Abstract][Full Text] [Related]
18. A Molecular Determinant of West Nile Virus Secretion and Morphology as a Target for Viral Attenuation.
Basset J; Burlaud-Gaillard J; Feher M; Roingeard P; Rey FA; Pardigon N
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269117
[TBL] [Abstract][Full Text] [Related]
19. Synergistic Internal Ribosome Entry Site/MicroRNA-Based Approach for Flavivirus Attenuation and Live Vaccine Development.
Tsetsarkin KA; Liu G; Volkova E; Pletnev AG
mBio; 2017 Apr; 8(2):. PubMed ID: 28420742
[TBL] [Abstract][Full Text] [Related]
20. Traditional and novel approaches to flavivirus vaccines.
Pugachev KV; Guirakhoo F; Trent DW; Monath TP
Int J Parasitol; 2003 May; 33(5-6):567-82. PubMed ID: 12782056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]